Cargando…
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state
Major depressive disorder (MDD) is associated with reduced concentrations of γ-aminobutyric acid (GABA) that are normalized by antidepressant therapies. Moreover, depressive-like phenotypes of GABA(A) receptor mutant mice can be reversed by treatment with conventional antidepressants drugs, as well...
Autores principales: | Fuchs, T, Jefferson, S J, Hooper, A, Yee, P-HP, Maguire, J, Luscher, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422144/ https://www.ncbi.nlm.nih.gov/pubmed/27821870 http://dx.doi.org/10.1038/mp.2016.188 |
Ejemplares similares
-
Disinhibition of somatostatin interneurons confers resilience to stress in male but not female mice
por: Jefferson, Sarah J., et al.
Publicado: (2020) -
Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition
por: Wang, Yao-Yi, et al.
Publicado: (2021) -
Prefrontal Disinhibition in Social Fear: A Vital Action of Somatostatin Interneurons
por: Wang, Jun, et al.
Publicado: (2020) -
Disinhibition-assisted long-term potentiation in the prefrontal-amygdala pathway via suppression of somatostatin-expressing interneurons
por: Ito, Wataru, et al.
Publicado: (2020) -
Bidirectional plasticity of GABAergic tonic inhibition in hippocampal somatostatin- and parvalbumin-containing interneurons
por: Wyroślak, Marcin, et al.
Publicado: (2023)